Table 1.
Summary of the study characteristics (N = 181).
| Characteristics | n (%) |
|---|---|
| WHO region | |
| Africa | 72 (40) |
| Americas | 49 (27) |
| Eastern Mediterranean | 8 (4) |
| Europe | 12 (7) |
| South-East Asia | 29 (16) |
| Western Pacific | 10 (6) |
| Article type | |
| Quantitative studies | 76 (42) |
| Feasibility/pilot studies | 44 (24) |
| Qualitative studies | 24 (13) |
| Mixed methods studies | 8 (4) |
| Program reports | 24 (13) |
| Discussions/commentaries | 4 (2) |
| Study setting | |
| Urban/peri-urban areas | 51 (28) |
| Rural areas | 39 (22) |
| Both urban and rural settings | 20 (11) |
| Not specify | 70 (39) |
| Cancer typea | |
| Cervical | 120 (66) |
| Breast | 43 (24) |
| Skin | 8 (4) |
| Colorectal | 5 (3) |
| Oral | 4 (2) |
| Prostate | 2 (1) |
| Lung | 1 (0.5) |
| Pediatric cancer | 2 (1) |
| Hereditary cancers | 3 (2) |
| Not specify | 6 (3) |
| Level of Preventionb | |
| Primary cancer prevention | 13 (7) |
| Secondary cancer prevention | 153 (86) |
| Both primary and secondary cancer prevention | 11 (6) |
WHO, World Health Organization.
a
n > 180 as some studies featured multiple cancer types.
b
n = 177 as some studies had multiple manuscripts.